凯发k8一触即发

　　Recently, National Institute of Pharmaceutical R&D Co., Ltd. (NIP Pharm), a subsidiary of CR Pharmaceutical Group, received the Notice of Drug Clinical Trial Approval from the ...

　　Recently, National Institute of Pharmaceutical R&D Co., Ltd. (NIP Pharm), a subsidiary of CR Pharmaceutical Group, received the Noti...

Detailed>>

Detailed +

2022.01

2022.01.22

Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passed the Consistency Evaluation of Quality and Efficacy of Generic Drugs

Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passe...

　　CR Double-Crane announced on January 22nd that its wholly-owned subsidiary Double-Crane Pharmaceutical (Anhui) received the Approval...

2021.11

2021.11.12

Novel Cancer Drug of CR Double-Crane Released and the Signing Ceremony between Haikou National Hi-tech Zone and CR Double-Crane Convened

Novel Cancer Drug of CR Double-Crane Released and the Signing Ceremony ...

　　At 9: 00 on November 11, 2021, a novel cancer drug was released by CR Double-Crane, and the signing ceremony between the company and...

2021.10

2021.10.09

NIP Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC

　　Recently, National Institute of Pharmaceutical R&D Co., Ltd. (NIP Pharm), a subsidiary of CR Pharmaceutical Group, received the Noti...

2021.10

2021.10.08

A Delegation Led by Zhang Boli Visiting CR Sanjiu

　　On October 7, a delegation led by Zhang Boli, an academician with the Chinese Academy of Engineering and recipient of the national h...

2021.09

2021.09.17

Remaining Committed to Charity - The CR Healthy Village Program Keeping up the Good Work

Remaining Committed to Charity - The CR Healthy Village Program Keeping...

　　The meeting for wrapping up the CR Healthy Village Program with the theme of “Boosting Primary-Level Medical Services and Supportin...

2021.08

2021.08.04

CR Double-Crane’s Sodium Valproate Tablets Fluconazole and Sodium Chloride Injection Passing Consistency Evaluation of Generic Drugs

CR Double-Crane’s Sodium Valproate Tablets Fluconazole and Sodium Chlo...

　　On August 4, CR Double-Crane issued an announcement that the Sodium Valproate Tablets produced by Hunan Xiangzhong Pharmaceutical Co...

2021.07

2021.07.21

CR Double-Crane and NOVITA signed an exclusive license agreement on the development, production and commercialization of NP-G2-044 Fascin inhibitor in Greater China.

CR Double-Crane and NOVITA signed an exclusive license agreement on the...

　　On July 21, CR Double-Crane Pharmaceuticals Co., Ltd (hereinafter referred to as CR Double-Crane), a subsidiary of China Resources P...

<bdo id='3K0J5'><sup id='5APYK'><div id='PHGEv'><bdo id='KlgJ0'></bdo></div></sup></bdo>

凯发k8一触即发

News Releases

News Releases

Headlines

NIP Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC

NIP Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC

NIP Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC

NIP Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC